Cigna's most recent trend suggests a bearish bias. One trading opportunity on Cigna is a Bear Call Spread using a strike $210.00 short call and a strike $230.00 long call offers a potential 16.62% return on risk over the next 27 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $210.00 by expiration. The full premium credit of $2.85 would be kept by the premium seller. The risk of $17.15 would be incurred if the stock rose above the $230.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Cigna is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Cigna is bearish.
The RSI indicator is at 25.05 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Cigna
4 Healthcare Stocks That Analysts Love
Thu, 19 Aug 2021 15:46:00 +0000
A drug maker, two insurers, and a medical-device company pass our screen of healthcare concerns with high analysts ratings and upside potential.
Cigna requires employees returning to office to be fully vaccinated
Wed, 18 Aug 2021 16:04:24 +0000
The health insurer joined a slew of companies such as Centene Corp, Morgan Stanley and Microsoft Corp across the healthcare, technology and financial sectors in mandating vaccines or tests for employees working from office. “It's clear we need to do more to stop the ongoing spread of COVID-19, and unlike many aspects of the pandemic, keeping our worksites as safe as possible is something we can control,” said Dr. Steve Miller, chief clinical officer of Cigna. Employees who must work onsite such as medical care providers and pharmacists should be fully vaccinated or receive two negative COVID-19 tests per week starting on Oct. 18, the company said.
Cigna Protects Its Workforce by Requiring COVID-19 Vaccinations or Testing for Employees Entering U.S. Worksites
Wed, 18 Aug 2021 15:15:00 +0000
With confirmed cases of COVID-19 on the rise in the United States, Cigna has established new requirements to help protect its workforce. Employees who work remotely must be fully vaccinated before entering any U.S. worksite, beginning September 7. Employees whose roles can only be performed onsite, such as medical care providers, pharmacists, pharmacy home delivery specialists, and others, must be fully vaccinated or receive two negative COVID-19 tests per week, beginning October 18, before ente
Fresenius Medical Care North America and Cigna Expand Efforts to Help People Living with Kidney Failure
Mon, 16 Aug 2021 12:00:00 +0000
Fresenius Medical Care North America (FMCNA) and Cigna (NYSE: CI) announce an expansion of their national effort to improve health outcomes and lower the cost of care for people living with kidney failure, or end stage renal disease (ESRD). The new agreement extends the program through at least 2023.
Cigna Launches World's First Voice-Activated Stress Test
Tue, 10 Aug 2021 01:00:00 +0000
Cigna International announces the launch of the Cigna StressWaves Test, a free online tool that analyses acoustic and semantic voice patterns to evaluate stress levels. The StressWaves Test was created in partnership with Ellipsis Health, a medical technology developer and leader in AI health and vocal biomarkers. The StressWaves Test will reveal the user's stress level, ranging from ‘Extremely Stressed' to ‘No Stress', along with a portrait that visualizes the effect of stress on the user's bod
Related Posts
Also on Market Tamer…
Follow Us on Facebook